Hmgb1 Inhibits Klotho Expression and Malignant Phenotype in Melanoma Cells by Activating NF-κB

Oncotarget - United States
doi 10.18632/oncotarget.12623
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Apigenin Inhibits Colonic Inflammation and Tumorigenesis by Suppressing STAT3-NF-κB Signaling

Oncotarget
Oncology
2017English

miR-130b, an Onco-miRNA in Bladder Cancer, Is Directly Regulated by NF-κB and Sustains NF-κB Activation by Decreasing Cylindromatosis Expression

Oncotarget
Oncology
2016English

NF-κB/RelA-PKM2 Mediates Inhibition of Glycolysis by Fenofibrate in Glioblastoma Cells

Oncotarget
Oncology
2015English

Increased cFLIP Expression in Thymic Epithelial Tumors Blocks Autophagy via NF-κB Signalling

Oncotarget
Oncology
2017English

The Metastatic Microenvironment: Melanoma-Microglia Cross-Talk Promotes the Malignant Phenotype of Melanoma Cells

International Journal of Cancer
Cancer ResearchOncology
2018English

TWEAK Activation of the Non-Canonical NF-κB Signaling Pathway Differentially Regulates Melanoma and Prostate Cancer Cell Invasion

Oncotarget
Oncology
2016English

Neferine Attenuates Acute Kidney Injury by Inhibiting NF-κB Signaling and Upregulating Klotho Expression

Frontiers in Pharmacology
Pharmacology
2019English

Dihydroartemisinin Attenuates Autoimmune Thyroiditis by Inhibiting the CXCR3/PI3K/AKT/NF-κB Signaling Pathway

Oncotarget
Oncology
2017English

Proteoglycan Expression Correlates With the Phenotype of Malignant and Non-Malignant EBV-positive B-Cell Lines

Oncotarget
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy